FY26 Cepheid GeneXpert Molecular Diagnostic Testing System Supplies and Services
Veterans Affairs · 261-NETWORK CONTRACT OFFICE 21 (36C261)
No listed company matched (Materiality N/A)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C26126D0003 in this department, oldest first.
- Jul 31, 2025 · this noticeAward NoticeCEPHEID Sunnyvale CA 94089 USA · $2.5M
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
What the notice says
Awardee: CEPHEID INC Number of Quotes Received: 1 Overall Value of IDIQ: $2,500,000.00
Who won similar work
4 award notices on SAM.gov in the last 24 months. Matched by: Same office (261-NETWORK CONTRACT OFFICE 21 (36C261)), same product/service code (PSC) 6550 and NAICS 325413.
Single-winner award sizes (4): middle half $604K to $931K, median $722K; range $600K to $1.2M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| ABBOTT LABORATORIES INC. · $ABT · $45.1B | 1 | $1.2M | May 20, 2026 |
| BIOMERIEUX INC | 1 | $840K | Jul 31, 2025 |
| ROCHE DIAGNOSTICS CORPORATION | 1 | $605K | Mar 11, 2026 |
| SIEMENS HEALTHCARE DIAGNOSTICS INC. | 1 | $600K | Oct 1, 2026 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- $ABT reported $45.1B revenue (12 months to Mar 31, 2026). The median single-winner award in these 4 past awards, $722K, is under 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 1, 2026SIEMENS HEALTHCARE DIAGNOSTICS INC.$600K6550--Blood Gas Analyzer Reagents, Controls, and Supplies IDIQNo listed company matched (Materiality N/A)
- May 20, 2026ABBOTT LABORATORIES INC.$1.2MAbbott Point of Care i-Stat Analyzer CPT - SFVAMCMateriality: <0.01% of $ABT revenue (Low) SEC
- Mar 11, 2026ROCHE DIAGNOSTICS CORPORATION$605KCPT clinical laboratory immunohistochemistry (IHC) and in-situ hybridization (ISH) analyzer with ReagentsNo listed company matched (Materiality N/A)
- Jul 31, 2025BIOMERIEUX INC$840KbioMerieux Reagents, Supplies, and Analyzer Preventative MaintenanceNo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 4 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 2 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (11 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $48K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 5 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 2 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.